Abstract
Background
It has been suggested that sentinel lymph node (SLN) biopsy for breast cancer may be less accurate after excisional biopsy of the primary tumor compared with core needle biopsy. Furthermore, some have suggested an improved ability to identify the SLN when total mastectomy is performed compared with lumpectomy. This analysis was performed to determine the impact of the type of breast biopsy (needle vs. excisional) or definitive surgical procedure (lumpectomy vs. mastectomy) on the accuracy of SLN biopsy.
Methods
The University of Louisville Breast Cancer Sentinel Lymph Node Study is a prospective multi-institutional study. Patients with clinical stage T1–2, N0 breast cancer were eligible. All patients underwent SLN biopsy and completion level I/II axillary dissection. Statistical comparison was performed by χ2 analysis.
Results
A total of 2206 patients were enrolled in the study. There were no statistically significant differences in SLN identification rate or false-negative rate between patients undergoing excisional versus needle biopsy. The SLN identification and false-negative rates also were not statistically different between patients who had total mastectomy compared with those who had a lumpectomy.
Conclusions
Excisional biopsy does not significantly affect the accuracy of SLN biopsy, nor does the type of definitive surgical procedure.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer.Ann Surg 1994;220:391–401.
Albertini JJ, Lyman GH, Cox C, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer.JAMA 1996;276:1818–22.
Giuliano AE, Jones RC, Brennan M, Statman R. Sentinel lymphadenectomy in breast cancer.J Clin Oncol 1997;15:2345–50.
McMasters KM, Tuttle TM, Carlson DJ, et al. Sentinel lymph node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used.J Clin Oncol 2000;18:2560–6.
Turner RR, Ollila DW, Krasne DL, Giuliano AE. Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma.Ann Surg 1997;226:271–8.
Veronesi U, Paganelli G, Galimberi V, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes.Lancet 1997;349:1864–7.
Veronesi U, Paganelli G, Viale G, et al. Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series.J Natl Cancer Inst 1999;91:368–73.
Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer: a multicenter validation study.N Engl J Med 1998;339: 941–6.
Bass SS, Cox CE, Ku NN Berman C, Reintgen DS. The role of sentinel lymph node biopsy in breast cancer.J Am Coll Surg 1999;189:183–94.
Hill AD, Mann GB, Borgen PI, Cody HS. Sentinel lymphatic mapping in breast cancer.J Am Coll Surg 1999;188:545–9.
O'Hea BJ, Hill ADK, El-Shirbiny AM, et al. Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center.J Am Coll Surg 1998;186:423–7.
Morrow M, Rademaker AW, Bethke KP, et al. Learning sentinel node biopsy: results of a prospective randomized trial of two techniques.Surgery 1999;126:714–22.
Tafra L, Lannin DR, Swanson MS, et al. Multicenter trial of sentinel node biopsy for breast cancer using both technetium sulfur colloid and isosulfan blue dye.Ann Surg 2001;233:51–9.
Winchester DJ, Sener SF, Winchester DP, et al. Sentinel lymphadenectomy for breast cancer: experience with 180 consecutive patients—efficacy of filtered technetium 99m sulphur colloid with overnight migration time.J Am Coll Surg 1999;188:597–603.
Sandrucci S, Casalegno PS, Percivale P, et al. Sentinel lymph node mapping and biopsy for breast cancer: a review of the literature relative to 4791 procedure.Tumori 1999;85:425–34.
Miltenburg DM, Miller C, Karamlou TB, Brunicardi FC. Meta-analysis of sentinel lymph node biopsy in breast cancer.J Surg Res 1999;84:138–42.
Borgstein PJ, Pijpers R, Comans EF, et al. Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection.J Am Coll Surg 1998;186:275–83.
Feldman SM, Krag DN, McNally RK, Moor BB, Weaver DL, Klein P. Limitation in gamma probe localization of the sentinel node in breast cancer patients with large excisional biopsy.J Am Coll Surg 1999;188:248–54.
Ollila DW, Guilano AE. Intraoperative lymphatic mapping and sentinel lymphadenectomy using isosulfan blue dye.Breast Dis 1998;8:297–300.
Cody HS. Sentinel lymph node mapping in breast cancer.Oncology 1999;13:25–34.
McMasters KM, Wong SL, Tuttle TM, et al. Preoperative lymphoscintigraphy for breast cancer does not improve the ability to accurately identify axillary sentinel lymph nodes.Ann Surg 2000;231:724–31.
McMasters KM, Wong SL, Martin RCG, et al. Dermal injection of radioactive colloid is superior to peritumoral injection for breast cancer sentinel lymph node biopsy: results of a multi-institutional study.Ann Surg 2001;233:676–87.
Wong SL, Chao C, Edwards MJ, et al. Accuracy of sentinel lymph node biopsy for patients with T2 and T3 breast cancers.Am Surg 2001;67:522–8.
McMasters KM, Wong SL, Chao C, et al. Defining the optimal surgeon experience for breast cancer sentinel lymph node biopsy: a model for implementation of new surgical techniques.Ann Surg 2001;234:292–300.
McMasters KM, Giuliano AE, Ross MI, et al. Sentinel-lymph-node biopsy for breast cancer—not yet the standard of care.N Engl J Med 1998;339:990–5.
Haigh PI, Hansen NM, Qi K, Giuliano AE. Biopsy method and excision volume do not affect success rate of subsequent sentinel lymph node dissection in breast cancer.Ann Surg Oncol 2000;7:21–7.
Miner TJ, Shriver CD, Jaques DP, Maniscalco-Theberge ME, Krag DN. Sentinel lymph node biopsy for breast cancer: the role of previous biopsy on patient eligibility.Am Surg 1999;65:493–9.
Guenther JM, Krishnamoorthy M, Tan LR. Sentinel lymphadenectomy for breast cancer in a community managed care setting.Cancer J Sci Am 1997;3:336–40.
Van der Ent FWC, Kengen RAM, van der Pol HAG, Hoofwijk AGM. Sentinel node biopsy in 70 unselected patients with breast cancer: increased feasibility by using 10 mCi radiocolloid in combination with blue dye tracer.Eur J Surg Oncol 1999;25:24–9.
Barnwell JM, Arredondo MA, Kollmorgen D, et al. Sentinel node biopsy in breast cancer.Ann Surg Oncol 1998;5:126–30.
Linehan DC, Hill ADK, Akhurst T, et al. Intradermal radiocolloid and intraparenchymal blue dye injection optimize sentinel node identification in breast cancer patients.Ann Surg Oncol 1999;6: 450–4.
Roumen RM, Geuskens LM, Valkenburg JG. In search of the true sentinel node by different injection techniques in breast cancer patients.Eur J Surg Oncol 1999;25:347–51.
Bland KI. Refining the optimal technical approach for sentinel node localization in breast cancer patients.Ann Surg Oncol 1999; 6:418–9.
Boolbol SK, Fey JV, Borgen PI, et al. Intradermal isotope injection: a highly accurate method of lymphatic mapping in breast carcinoma.Ann Surg Oncol 2001;8:20–4.
Miner TJ, Shriver CD, Jaques DP, et al. Ultrasonographically guided injection improves localization of the radiolabeled sentinel lymph node in breast cancer.Ann Surg Oncol 1998;5:315–21.
Author information
Authors and Affiliations
Consortia
Corresponding author
Rights and permissions
About this article
Cite this article
Wong, S.L., Edwards, M.J., Chao, C. et al. The effect of prior breast biopsy method and concurrent definitive breast procedure on success and accuracy of sentinel lymph node biopsy. Annals of Surgical Oncology 9, 272–277 (2002). https://doi.org/10.1007/BF02573065
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02573065